Form 4 · Filed Jun 24, 2026, 11:19 PM UTC
ELVN/Enliven Therapeutics, Inc.
ORBIMED ADVISORS LLC — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | S | sell | 24,846 | $45 | $1,127,511 | 220,882 |
| Jun 22, 2026 | S | sell | 1,477 | $45 | $66,465 | 219,405 |
| Jun 22, 2026 | S | sell | 787,024 | $45 | $35,715,149 | 6,601,878 |
| Jun 22, 2026 | S | sell | 46,776 | $45 | $2,104,920 | 6,555,102 |
Source: SEC EDGAR raw filing ↗ · Accession 0000947871-26-000653